Scholar Rock Holding Corporation
SRRK
Kedudukan dalam Saham
#3428
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to... Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
Harga Saham
$41.58
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$5.06B
Perubahan (1 hari)
3.34%
Perubahan (1 tahun)
47.62%
Negara
US
Perdagangan Scholar Rock Holding Corporation (SRRK)
Kategori
Healthcare
Hasil untuk Scholar Rock Holding Corporation (SRRK)
Hasil pada Jun 2026 TTM: 0.00
Menurut laporan kewangan terkini daripada Scholar Rock Holding Corporation, hasil semasa syarikat (TTM) ialah 0.00. Pada tahun 2023, syarikat memperoleh hasil sebanyak 0.00 penurunan berbanding hasil pada tahun 2022 iaitu $33.19M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Scholar Rock Holding Corporation dari 2016 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | $33.19M | 76.41% |
| 2021 | $18.82M | 22.16% |
| 2020 | $15.40M | -24.83% |
| 2019 | $20.49M | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | -100.00% |
| 2016 | $379.00K | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| - | - |
CH
|
|
| $6.02B | - |
NL
|
